Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis.

Antiviral Agents Cost-Benefit Analysis Health Status Hepatitis C Humans Liver Diseases / diagnosis Quality of Life Surveys and Questionnaires
EuroQOL 5-dimensions 5-levels Health Utilities Index-Mark Quality of life RAND-36 Short from-36

Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
21 Aug 2022
Historique:
received: 13 01 2022
revised: 26 04 2022
accepted: 24 07 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

Health utility assessments have been developed for various conditions, including chronic liver disease. Health utility scores are required for socio-economic evaluations, which can aid the distribution of national budgets. However, the standard health utility assessment scores for specific health conditions are largely unknown. To summarize the health utility scores, including the EuroQOL 5-dimensions 5-levels (EQ-5D-5L), EuroQol-visual analogue scale, short from-36 (SF-36), RAND-36, and Health Utilities Index (HUI)-Mark2/Mark3 scores, for the normal population and chronic liver disease patients. A systematic literature search of PubMed and MEDLINE, including the Cochrane Library, was performed. Meta-analysis was performed using the RevMan software. Multiple means and standard deviations were combined using the StatsToDo online web program. The EQ-5D-5L and SF-36 can be used for health utility evaluations during antiviral therapy for hepatitis C. HUI-Mark2/Mark3 indicated that the health utility scores of hepatitis B patients are roughly 30% better than those of hepatitis C patients. The EQ-5D-5L is the most popular questionnaire for health utility assessments. Health assessments that allow free registration would be useful for evaluating health utility in patients with liver disease.

Sections du résumé

BACKGROUND BACKGROUND
Health utility assessments have been developed for various conditions, including chronic liver disease. Health utility scores are required for socio-economic evaluations, which can aid the distribution of national budgets. However, the standard health utility assessment scores for specific health conditions are largely unknown.
AIM OBJECTIVE
To summarize the health utility scores, including the EuroQOL 5-dimensions 5-levels (EQ-5D-5L), EuroQol-visual analogue scale, short from-36 (SF-36), RAND-36, and Health Utilities Index (HUI)-Mark2/Mark3 scores, for the normal population and chronic liver disease patients.
METHODS METHODS
A systematic literature search of PubMed and MEDLINE, including the Cochrane Library, was performed. Meta-analysis was performed using the RevMan software. Multiple means and standard deviations were combined using the StatsToDo online web program.
RESULTS RESULTS
The EQ-5D-5L and SF-36 can be used for health utility evaluations during antiviral therapy for hepatitis C. HUI-Mark2/Mark3 indicated that the health utility scores of hepatitis B patients are roughly 30% better than those of hepatitis C patients.
CONCLUSION CONCLUSIONS
The EQ-5D-5L is the most popular questionnaire for health utility assessments. Health assessments that allow free registration would be useful for evaluating health utility in patients with liver disease.

Identifiants

DOI: 10.3748/wjg.v28.i31.4442 PMID: 36159009 PMC: PMC9453766
pubmed: 36159009
doi: 10.3748/wjg.v28.i31.4442
pmc: PMC9453766
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

4442-4455

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: All authors have nothing to disclose.

Références

Milbank Q. 2005;83(4):691-729
pubmed: 16279964
BMJ. 1993 May 29;306(6890):1437-40
pubmed: 8518639
PLoS One. 2019 May 9;14(5):e0215764
pubmed: 31071105
BMC Geriatr. 2020 Feb 5;20(1):44
pubmed: 32024479
Gut. 2006 Sep;55(9):1332-8
pubmed: 15994216
Liver Int. 2021 Nov;41(11):2611-2621
pubmed: 34219359
BMJ. 2001 May 19;322(7296):1240-3
pubmed: 11358783
Patient Prefer Adherence. 2018 Dec 04;12:2593-2603
pubmed: 30584283
Clin Microbiol Infect. 2020 Aug;26(8):1093.e5-1093.e8
pubmed: 32353413
Qual Life Res. 2021 Mar;30(3):647-673
pubmed: 33284428
Scand J Gastroenterol. 2009;44(7):878-87
pubmed: 19437190
Am J Gastroenterol. 2001 Feb;96(2):579-83
pubmed: 11232711
Qual Life Res. 2017 Feb;26(2):349-357
pubmed: 27534773
Hepatol Res. 2018 Jun;48(7):509-520
pubmed: 29316059
Liver Transpl. 2002 Mar;8(3):263-70
pubmed: 11910572
Br Med Bull. 2010;96:5-21
pubmed: 21037243
J Spinal Cord Med. 2014 Mar;37(2):128-38
pubmed: 24559417
Gastroenterology. 2006 Aug;131(2):478-84
pubmed: 16890602
ACS Cent Sci. 2021 Apr 28;7(4):508-509
pubmed: 34056081
J Hepatol. 2013 Mar;58(3):460-6
pubmed: 23149064
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
Am J Gastroenterol. 2003 Mar;98(3):630-8
pubmed: 12650799
Qual Life Res. 2013 Sep;22(7):1707-16
pubmed: 23192232
Liver Int. 2009 Mar;29(3):449-58
pubmed: 19267865
Liver Int. 2007 Oct;27(8):1119-25
pubmed: 17845541
Gen Thorac Cardiovasc Surg. 2019 Dec;67(12):1056-1061
pubmed: 31098867
Liver Int. 2020 Nov;40(11):2630-2642
pubmed: 32851764
Turk J Gastroenterol. 2019 Sep;30(9):801-806
pubmed: 31530524
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Liver Transpl. 2008 Mar;14(3):321-6
pubmed: 18306356
Lancet. 2019 Apr 6;393(10179):1392-1394
pubmed: 30765125
Qual Life Res. 2016 Mar;25(3):707-19
pubmed: 26303761
World J Clin Cases. 2018 Nov 6;6(13):589-599
pubmed: 30430114

Auteurs

Tomohiro Ishinuki (T)

Department of Nursing, Surgical Sciences, Sapporo Medical University, Sapporo 0608556, Japan.

Shigenori Ota (S)

Departments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.

Kohei Harada (K)

Department of Radiology, Sapporo Medical University, Sapporo 0608543, Japan.

Masaki Kawamoto (M)

Departments of Surgery, Nemuro City Hospital, Nemuro 0870008, Japan.

Makoto Meguro (M)

Departments of Surgery, Sapporo Satozuka Hospital, Sapporo 0040811, Japan.

Goro Kutomi (G)

Departments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.

Hiroomi Tatsumi (H)

Department of Intensive Care Medicine, Sapporo Medical University, Sapporo 0608543, Japan.

Keisuke Harada (K)

Department of Emergency Medicine, Sapporo Medical University, Sapporo 0608543, Japan.

Koji Miyanishi (K)

Department of Medical Oncology, Sapporo Medical University, Sapporo 0608543, Japan.

Toru Kato (T)

Departments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.

Toshio Ohyanagi (T)

Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo 0608556, Japan.

Thomas T Hui (TT)

Departments of Surgery, Stanford University School of Medicine, Stanford, 94598, United States.

Toru Mizuguchi (T)

Department of Nursing, Surgical Sciences, Sapporo Medical University, Sapporo 0608556, Japan. tmizu@sapmed.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Current standard values of health utility...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › Current standard values of health utility...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Current standard values of health utility...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Hépatite › Hépatites virales humaines › Hépatite C › Current standard values of health utility...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Current standard values of health utility...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Current standard values of health utility...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Current standard values of health utility...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Current standard values of health utility...